|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.99 USD | +0.01% |
|
-.--% | - |
| Market Cap | 3.32B 2.87B 2.64B 2.47B 4.64B 316B 4.71B 31.21B 12.17B 154B 12.46B 12.2B 532B | P/E Ratio 2023 |
-317x | P/E Ratio 2024 | 69.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.48B 3B 2.77B 2.59B 4.85B 331B 4.93B 32.68B 12.74B 161B 13.05B 12.77B 557B | EV / Sales 2023 |
1.55x | EV / Sales 2024 | 1.33x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
| 30/09/25 | A CEO's Playbook For Navigating Crisis And Building Trust (Video) | AQ |
| 30/07/25 | Amedisys: Q2 Earnings Snapshot | AQ |
| 30/07/25 | Amedisys : Second Quarter 2025 Earnings Release Supplemental Slides | PU |
| 30/07/25 | Amedisys Reports Second Quarter 2025 Financial Results | AQ |
| 24/04/25 | Amedisys: Q1 Earnings Snapshot | AQ |
| 1 day | +0.01% |
| 1 year | 95.55 |  | 101.02 |
| 3 years | 82.15 | | 101.02 |
| 5 years | 69.36 | | 276.21 |
| 10 years | 34.58 | | 325.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Ginn
DFI | Director of Finance/CFO | 57 | 06/10/2017 |
Keith Blanchard
CTO | Chief Tech/Sci/R&D Officer | - | - |
Denise Bohnert
CMP | Compliance Officer | 48 | 01/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 14/08/25 | Issuer sale | Director | 16,031 | 0.0489% | ||
| 14/08/25 | Issuer sale | Director | 9,818 | 0.0300% | ||
| 14/08/25 | Issuer sale | Director | 9,335 | 0.0285% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 2.24B 1.93B 1.78B 1.67B 3.12B 213B 3.17B 21.02B 8.19B 103B 8.39B 8.21B 358B | 2.35B 2.03B 1.87B 1.75B 3.28B 223B 3.33B 22.07B 8.6B 109B 8.81B 8.63B 376B |
| Net income | -9.75M -8.42M -7.76M -7.26M -13.61M -926M -13.82M -91.6M -35.71M -451M -36.58M -35.8M -1.56B | 43.23M 37.34M 34.41M 32.21M 60.36M 4.11B 61.29M 406M 158M 2B 162M 159M 6.93B |
| Net Debt | 361M 312M 287M 269M 504M 34.29B 511M 3.39B 1.32B 16.69B 1.35B 1.33B 57.79B | 156M 135M 124M 116M 218M 14.83B 221M 1.47B 572M 7.22B 586M 573M 25B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- AMED Stock
Select your edition
All financial news and data tailored to specific country editions
